These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37808919)

  • 1. Study of Drug Target Identification and Associated Molecular Mechanisms for the Therapeutic Activity and Hair Follicle Induction of Two Ashwagandha Extracts Having Differential Withanolide Constitutions.
    Cavaleri F; Chattopadhyay S; Palsule V; Kar PK; Chatterjee R
    J Nutr Metab; 2023; 2023():9599744. PubMed ID: 37808919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of Drug Targets Associated With Oncogenesis and Cancer Cell Survival and the Therapeutic Activity of Engineered Ashwagandha Extract Having Differential Withanolide Constitutions.
    Cavaleri F; Chattopadhyay S; Palsule V; Kar PK; Chatterjee R
    Integr Cancer Ther; 2024; 23():15347354231223499. PubMed ID: 38281118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.
    Sun GY; Li R; Cui J; Hannink M; Gu Z; Fritsche KL; Lubahn DB; Simonyi A
    Neuromolecular Med; 2016 Sep; 18(3):241-52. PubMed ID: 27209361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraction Optimization for Phenolic- and Withanolide-Rich Fractions from
    Kumar S; Singh R; Gajbhiye N; Dhanani T
    J AOAC Int; 2018 Nov; 101(6):1773-1780. PubMed ID: 29945694
    [No Abstract]   [Full Text] [Related]  

  • 5. β-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of ashwagandha (Withania somnifera) and its constituent Withanolide A.
    Kurapati KR; Samikkannu T; Atluri VS; Kaftanovskaya E; Yndart A; Nair MP
    PLoS One; 2014; 9(11):e112818. PubMed ID: 25415340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red laser-mediated alterations in seed germination, growth, pigments and withanolide content of Ashwagandha [Withania somnifera (L.) Dunal].
    Thorat SA; Poojari P; Kaniyassery A; Kiran KR; Satyamoorthy K; Mahato KK; Muthusamy A
    J Photochem Photobiol B; 2021 Mar; 216():112144. PubMed ID: 33556702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withanolide A is inherently de novo biosynthesized in roots of the medicinal plant Ashwagandha (Withania somnifera).
    Sangwan RS; Das Chaurasiya N; Lal P; Misra L; Tuli R; Sangwan NS
    Physiol Plant; 2008 Jun; 133(2):278-87. PubMed ID: 18312497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ashwagandha (Withania somnifera) root extract attenuates hepatic and cognitive deficits in thioacetamide-induced rat model of hepatic encephalopathy via induction of Nrf2/HO-1 and mitigation of NF-κB/MAPK signaling pathways.
    Khalil HMA; Eliwa HA; El-Shiekh RA; Al-Mokaddem AK; Hassan M; Tawfek AM; El-Maadawy WH
    J Ethnopharmacol; 2021 Sep; 277():114141. PubMed ID: 33905819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing nitric oxide generation.
    Pathak P; Shukla P; Kanshana JS; Jagavelu K; Sangwan NS; Dwivedi AK; Dikshit M
    J Ethnopharmacol; 2021 Oct; 278():114296. PubMed ID: 34090907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ashwagandha in brain disorders: A review of recent developments.
    Zahiruddin S; Basist P; Parveen A; Parveen R; Khan W; Gaurav ; Ahmad S
    J Ethnopharmacol; 2020 Jul; 257():112876. PubMed ID: 32305638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcritical water extraction of withanosides and withanolides from ashwagandha (Withania somnifera L) and their biological activities.
    Nile SH; Nile A; Gansukh E; Baskar V; Kai G
    Food Chem Toxicol; 2019 Oct; 132():110659. PubMed ID: 31276745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An updated review on phytochemistry and molecular targets of
    Bashir A; Nabi M; Tabassum N; Afzal S; Ayoub M
    Front Pharmacol; 2023; 14():1049334. PubMed ID: 37063285
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhanced withanolide production by overexpression of squalene synthase in Withania somnifera.
    Grover A; Samuel G; Bisaria VS; Sundar D
    J Biosci Bioeng; 2013 Jun; 115(6):680-5. PubMed ID: 23313565
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Hyun J; Im J; Kim SW; Kim HY; Seo I; Bhang SH
    Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hair roots induction and culture of Withania somnifera and its withanolide A synthesis].
    Wang FY; Sun YM; Lv CP; Cheng MQ; Zhang L; Sun M
    Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):790-4. PubMed ID: 25204166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated System Pharmacology and
    Hannan MA; Dash R; Haque MN; Choi SM; Moon IS
    CNS Neurol Disord Drug Targets; 2020; 19(7):541-556. PubMed ID: 32748763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolite Profiling in Withania somnifera Roots Hydroalcoholic Extract Using LC/MS, GC/MS and NMR Spectroscopy.
    Trivedi MK; Panda P; Sethi KK; Jana S
    Chem Biodivers; 2017 Mar; 14(3):. PubMed ID: 27743505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNAi of Sterol Methyl Transferase1 Reveals its Direct Role in Diverting Intermediates Towards Withanolide/Phytosterol Biosynthesis in Withania somnifera.
    Pal S; Rastogi S; Nagegowda DA; Gupta MM; Shasany AK; Chanotiya CS
    Plant Cell Physiol; 2019 Mar; 60(3):672-686. PubMed ID: 30541044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.
    Ven Murthy MR; Ranjekar PK; Ramassamy C; Deshpande M
    Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):238-46. PubMed ID: 20528765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAρ receptors.
    Candelario M; Cuellar E; Reyes-Ruiz JM; Darabedian N; Feimeng Z; Miledi R; Russo-Neustadt A; Limon A
    J Ethnopharmacol; 2015 Aug; 171():264-72. PubMed ID: 26068424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.